Somatogen
Executive Summary
Boulder, Colo.-based blood products R&D firm is involved in litigation with "three individuals who made short-term loans to the company" in 1986-88. The litigation centers on "claims that stock purchase warrants issued to individuals in conjunction with the loans should have been adjusted to allow the individuals to purchase more stock at a lower price," Somatogen says. The company is countersuing. Somatogen is not being sued by its venture capital investors as reported in "The Pink Sheet" (Aug. 10. p. 10).